NCT06735599

Brief Summary

The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Sep 2024Jan 2027

Study Start

First participant enrolled

September 17, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 16, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

March 27, 2026

Status Verified

March 1, 2025

Enrollment Period

2.3 years

First QC Date

November 5, 2024

Last Update Submit

March 23, 2026

Conditions

Keywords

BlueberriesHypertensionOverweightHigh Blood PressureEndothelial FunctionCognitive FunctionDietary interventionfunctional foodsgut microbiotaarterial stiffnessmicrovascular function

Outcome Measures

Primary Outcomes (2)

  • Ambulatory Blood Pressure

    Assessment of whole-day ambulatory blood pressure during daytime and nighttime periods.

    Baseline, 4 weeks, and 8 weeks

  • Pulse Wave Velocity

    Arterial Stiffness will be measured by pulse wave velocity using SphygmCor

    Baseline, 4 weeks, and 8 weeks

Secondary Outcomes (11)

  • Reactive Hyperemia Index

    Baseline, 4 weeks, and 8 weeks

  • Gut Microbiota Composition

    Baseline, 4 weeks, and 8 weeks

  • Global Cognitive Ability

    Screening

  • Performance Validity

    Baseline, 4 weeks, and 8 weeks

  • Verbal Memory & Recognition

    Baseline, 4 weeks, and 8 weeks

  • +6 more secondary outcomes

Other Outcomes (4)

  • Percent Maximal Microvascular Blood Flow

    Baseline, 4 weeks, and 8 weeks

  • Circulating Markers of Inflammation and Oxidative Stress

    Baseline, 4 weeks, and 8 weeks

  • Urinary Polyphenolic Metabolites

    Baseline, 4 weeks, and 8 weeks

  • +1 more other outcomes

Study Arms (2)

Wild Blueberry

EXPERIMENTAL

22 g of freeze-dried wild blueberry freeze-dried powder per day

Dietary Supplement: Wild Blueberry

Placebo

PLACEBO COMPARATOR

22 g of freeze-dried macronutrient-matched placebo powder per day

Dietary Supplement: Placebo

Interventions

PlaceboDIETARY_SUPPLEMENT

Daily consumption of 22 g of freeze-dried macronutrient-matched placebo powder for 8 weeks

Placebo
Wild BlueberryDIETARY_SUPPLEMENT

Daily consumption of 22 g of freeze-dried wild blueberry freeze-dried powder for 8 weeks

Wild Blueberry

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals 45-65 years of age
  • Diagnosis of elevated blood pressure or stage 1 hypertension (systolic blood pressure = 120-139 mmHg and/or diastolic blood pressure = 80-89 mmHg) for at least 6 months
  • BMI 25-35 kg/m2 via anthropometric measurements.
  • Ability to give consent

You may not qualify if:

  • Allergies to berries
  • Use of one hypertensive drug for less than three months
  • Use of more than one anti-hypertensive or statin drug, insulin, antibiotics, and anti-inflammatory drugs, active cancer, gastrointestinal, renal, cardiovascular, thyroid, and neurological disorders or severe head injury
  • Smoking
  • Alcohol consumption (\>2 drinks/day)
  • Consuming antioxidant, probiotic, and prebiotic supplements
  • Pregnant or lactating
  • Participating in a weight loss program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Georgia State University

Atlanta, Georgia, 30303, United States

RECRUITING

Related Publications (4)

  • Krikorian R, Skelton MR, Summer SS, Shidler MD, Sullivan PG. Blueberry Supplementation in Midlife for Dementia Risk Reduction. Nutrients. 2022 Apr 13;14(8):1619. doi: 10.3390/nu14081619.

    PMID: 35458181BACKGROUND
  • Johnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, Feresin RG, Elam ML, Hooshmand S, Payton ME, Arjmandi BH. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015 Mar;115(3):369-377. doi: 10.1016/j.jand.2014.11.001. Epub 2015 Jan 8.

    PMID: 25578927BACKGROUND
  • Cassidy A, O'Reilly EJ, Kay C, Sampson L, Franz M, Forman JP, Curhan G, Rimm EB. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011 Feb;93(2):338-47. doi: 10.3945/ajcn.110.006783. Epub 2010 Nov 24.

    PMID: 21106916BACKGROUND
  • Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.

    PMID: 35078371BACKGROUND

MeSH Terms

Conditions

HypertensionHyperemiaOverweightInflammation

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Rafaela G Feresin, PhD

    Georgia State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rafaela G Feresin, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 5, 2024

First Posted

December 16, 2024

Study Start

September 17, 2024

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

March 27, 2026

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations